Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-615P is a member of the family of U6 small nuclear RNA pseudogenes, located on chromosome 4 in the human genome[4]. Pseudogenes are non-functional segments of DNA that resemble functional genes but generally lack biological activity and do not encode active proteins or RNAs. While parental U6 snRNA plays a vital role in pre-mRNA splicing as a core catalytic component of the spliceosome[3][5], RNU6-615P does not participate in this process. U6 snRNA pseudogenes are commonly found throughout the genome and are produced during retrotransposition events, often mediated by LINE-1 elements[7]. These pseudogenes may serve as markers of genomic retrotransposition activity and evolutionary dynamics, but they are not considered functional therapeutic targets nor do they have direct disease implications[1][7]. There is nothing to suggest that RNU6-615P encodes a protein, functions in cell signaling, or acts as a therapeutic receptor or enzyme. It should not be listed as a candidate for structured drug target databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 615, pseudogene (RNU6-615P).